知名基金经理，转行当上A股董秘！

Group 1 - The article discusses the trend of fund managers transitioning to roles as company secretaries in listed companies, indicating a shift beyond asset management [1][4] - Jiang Ying has been appointed as the new company secretary of Luoxin Pharmaceutical, marking a notable case of a fund manager moving into this role [2][3] - Jiang Ying has a strong academic background with dual degrees in Science and Economics from Peking University, and a Master's in Management and Finance from Hong Kong University, but lacks prior experience as a company secretary [3] Group 2 - Luoxin Pharmaceutical reported a revenue of 1.077 billion yuan for the first half of 2025, a year-on-year decrease of 14.45%, while achieving a net profit of 17.695 million yuan, indicating a turnaround from losses in the previous year [4] - The company has faced significant performance fluctuations in recent years, attributed to factors such as the COVID-19 pandemic, impairment provisions, and adjustments in financial liabilities [4] - The trend of hiring former financial professionals as company secretaries has been noted, with examples including Wang Shangbo from Hongtu Innovation Fund and Liu Haoyu from Dongwu Fund, who have transitioned to roles in listed companies [4]